Clinical Trials Browser

Phase 2 × Adenocarcinoma × lenvatinib × Clear all

NCT07368985 2026-01-27

Pembrolizumab and Lenvatinib in Patients With High Risk Locally Advanced Cervix Cancer

Phase 2 Not yet recruiting

Adenocarcinoma, Uterine Cervical Neoplasms

NCT04699071 2021-10-21

Trial of Lenvatinib Plus PembrolizumAb in Recurrent Gynecological Clear Cell Adenocarcinomas (LARA)

Phase 2 Unknown

Adenocarcinoma